196 related articles for article (PubMed ID: 3954945)
1. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Stephens TC; Adams K; Peacock JH
Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
[TBL] [Abstract][Full Text] [Related]
2. Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours.
Stephens TC; Adams K; Peacock JH
Br J Cancer; 1984 Jul; 50(1):77-83. PubMed ID: 6743517
[TBL] [Abstract][Full Text] [Related]
3. Development of MeCCNU-resistance in clonally derived lines of Lewis lung carcinoma.
McMillan TJ; Stephens TC; Peacock JH; Steel GG
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):801-5. PubMed ID: 3653197
[TBL] [Abstract][Full Text] [Related]
4. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
5. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.
Stephens TC; Adams K; Peacock JH; Steel GG
Radiother Oncol; 1986 Feb; 5(2):137-46. PubMed ID: 3704188
[TBL] [Abstract][Full Text] [Related]
6. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
Joiner MC; Steel GG; Stephens TC
Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
[TBL] [Abstract][Full Text] [Related]
7. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
Teicher BA; Holden SA; Rose CM
Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
[TBL] [Abstract][Full Text] [Related]
8. Nitrosourea combinations in lung cancer.
Livingston RB
Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
[TBL] [Abstract][Full Text] [Related]
9. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
Schmid FA; Otter GM; Chen CF
Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
[TBL] [Abstract][Full Text] [Related]
10. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
11. Nitrosoureas as single agents in the treatment of pulmonary cancer.
Wolf J
Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697
[No Abstract] [Full Text] [Related]
12. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
Zeller WJ; Eisenbrand G; Fiebig HH
J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
[TBL] [Abstract][Full Text] [Related]
13. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
Feola JM; Maruyama Y
Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
[TBL] [Abstract][Full Text] [Related]
14. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
Hill RP; Stanley JA
Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
[TBL] [Abstract][Full Text] [Related]
15. Preferential action of liposome-entrapped 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on lung metastasis of Lewis lung carcinoma as compared with the free drug.
Inaba M; Yoshida N; Tsukagoshi S
Gan; 1981 Jun; 72(3):341-5. PubMed ID: 7319193
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
Zeller WJ; Berger M
Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
[TBL] [Abstract][Full Text] [Related]
18. The effect of BCNU, CCNU and MeCCNU in the prevention of the development of tumors of the nervous system.
Pezzotta S; Agradi E; Paoletti P
Pharmacol Res Commun; 1975 Feb; 07(1):49-53. PubMed ID: 1153462
[No Abstract] [Full Text] [Related]
19. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
20. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
Stephens TC; Peacock JH
Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
